Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys
- 1 April 1992
- journal article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 17 (2), 103-113
- https://doi.org/10.1007/bf03188778
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Carrier-mediated uptake of pravastatin by rat hepatocytes in primary cultureBiochemical Pharmacology, 1992
- Metabolism of pravastatin sodium in isolated rat hepatocytes. I. Glutathione conjugate formation reactionXenobiotica, 1992
- Metabolism of pravastatin sodium in isolated rat hepatocytes. II. Structure elucidation of the metabolites by n.m.r. spectroscopyXenobiotica, 1991
- THE PHYSIOLOGICAL DISPOSITION OF LOVASTATIN1989
- Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)Atherosclerosis, 1989
- The Effect of CS-514, an Inhibitor of HMG-CoA Reductase, on Serum Lipids in Healthy VolunteersAtherosclerosis, 1986
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- 3.ALPHA.-Hydroxy-ML-236B(3.ALPHA.-hydroxycompactin), microbial transformation product of ML-236B (compactin)The Journal of Antibiotics, 1983
- 6.ALPHA.-Hydroxy-iso-ML-236B (6.ALPHA.-hydroxy-iso-compactin) and ML-236A, Microbial transformation products of ML-236B.The Journal of Antibiotics, 1983